Zobrazeno 1 - 10
of 19 171
pro vyhledávání: '"Therapeutic Equivalency"'
Autor:
Inal A; Faculty of Medicine, Department of Pharmacology, Hakan Cetinsaya Good Clinical Practise and Research Center, Erciyes University, Kayseri, Türkiye. ainal@erciyes.edu.tr., Sezer Z; Faculty of Medicine, Department of Pharmacology, Hakan Cetinsaya Good Clinical Practise and Research Center, Erciyes University, Kayseri, Türkiye., Pinarbasli O; ILKO Pharmaceuticals, Ankara, Türkiye., Bulut B; ILKO Pharmaceuticals, Ankara, Türkiye., Reinsch M; Analytisches Zentrum Biopharm GmbH, Berlin, Germany., Martin W; Pharmakin Consulting Services UG, Neu-Ulm, Germany., Mazicioglu MM; Faculty of Medicine, Department of Family Medicine, Hakan Cetinsaya Good Clinical Practise and Research Center, Erciyes University, Kayseri, Türkiye., Koru SA; IDEAL Biyolojik Urunler ve Ilac Danismanlik Egitimi Ltd. Sti., Ankara, Türkiye.
Publikováno v:
BMC pharmacology & toxicology [BMC Pharmacol Toxicol] 2024 Oct 23; Vol. 25 (1), pp. 80. Date of Electronic Publication: 2024 Oct 23.
Autor:
Su R; Phase I Clinical Trial Center, Bishan hospital of Chongqing medical university, Chongqing, 402760, China., Wan L; Phase I Clinical Trial Center, Bishan hospital of Chongqing medical university, Chongqing, 402760, China., Tao Y; Office of academic research, the First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China., Zhu M; Phase I Clinical Trial Center, Bishan hospital of Chongqing medical university, Chongqing, 402760, China., Pu J; Phase I Clinical Trial Center, Bishan hospital of Chongqing medical university, Chongqing, 402760, China., Li Z; Phase I Clinical Trial Center, Bishan hospital of Chongqing medical university, Chongqing, 402760, China., Chen Y; Phase I Clinical Trial Center, Bishan hospital of Chongqing medical university, Chongqing, 402760, China., Tang C; Phase I Clinical Trial Center, Bishan hospital of Chongqing medical university, Chongqing, 402760, China. tcyongwzj@163.com.
Publikováno v:
Scientific reports [Sci Rep] 2024 Oct 21; Vol. 14 (1), pp. 24687. Date of Electronic Publication: 2024 Oct 21.
Autor:
Javidnia M; Office of Study Integrity and Surveillance, Office of Translational Sciences, Center for Drug Evaluation and Research, United States Food and Drug Administration, United States Department of Health and Human Services, 10903 New Hampshire Ave, Silver Spring, Maryland, 20993-0002, USA., Irier HA; Office of Study Integrity and Surveillance, Office of Translational Sciences, Center for Drug Evaluation and Research, United States Food and Drug Administration, United States Department of Health and Human Services, 10903 New Hampshire Ave, Silver Spring, Maryland, 20993-0002, USA., Kassim S; Office of Study Integrity and Surveillance, Office of Translational Sciences, Center for Drug Evaluation and Research, United States Food and Drug Administration, United States Department of Health and Human Services, 10903 New Hampshire Ave, Silver Spring, Maryland, 20993-0002, USA., Cho SJ; Office of Study Integrity and Surveillance, Office of Translational Sciences, Center for Drug Evaluation and Research, United States Food and Drug Administration, United States Department of Health and Human Services, 10903 New Hampshire Ave, Silver Spring, Maryland, 20993-0002, USA. seongeun.cho@fda.hhs.gov.
Publikováno v:
AAPS PharmSciTech [AAPS PharmSciTech] 2024 Oct 10; Vol. 25 (7), pp. 240. Date of Electronic Publication: 2024 Oct 10.
Autor:
Bjugård Nyberg H; Department of Pharmacy, Uppsala University, Uppsala, Sweden., Chen X; Department of Pharmacy, Uppsala University, Uppsala, Sweden., Donnelly M; Division of Quantitative Methods and Modelling, Office of Research and Standards, Office of Generic Drugs, Food and Drug Administration, Silver Spring, Maryland, USA., Fang L; Division of Quantitative Methods and Modelling, Office of Research and Standards, Office of Generic Drugs, Food and Drug Administration, Silver Spring, Maryland, USA., Zhao L; Division of Quantitative Methods and Modelling, Office of Research and Standards, Office of Generic Drugs, Food and Drug Administration, Silver Spring, Maryland, USA., Karlsson MO; Department of Pharmacy, Uppsala University, Uppsala, Sweden., Hooker AC; Department of Pharmacy, Uppsala University, Uppsala, Sweden.
Publikováno v:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2024 Oct; Vol. 13 (10), pp. 1748-1761. Date of Electronic Publication: 2024 Aug 28.
Autor:
Purohit V; Translational Clinical Sciences, Pfizer Worldwide Research and Development, Groton, Connecticut, USA., Sagawa K; Pharmaceutical Science, Drug Product Design, Pfizer Worldwide Research and Development, Groton, Connecticut, USA., Hsu HJ; Pharmaceutical Science, Drug Product Design, Pfizer Worldwide Research and Development, Groton, Connecticut, USA., Kushner J; Pharmaceutical Science, Drug Product Design, Pfizer Worldwide Research and Development, Groton, Connecticut, USA., Dowty ME; Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, USA., Tse S; Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research and Development, Groton, Connecticut, USA., Lin J; Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research and Development, Groton, Connecticut, USA., Blanchard A; Pharmaceutical Science, Analytical Research and Development, Pfizer Worldwide Research and Development, Groton, Connecticut, USA., Mukherjee A; Translational Clinical Sciences, Pfizer Worldwide Research and Development, Groton, Connecticut, USA., Le V; Global Biometrics and Data Management, New York, New York, USA., Chang C; Translational Clinical Sciences, Pfizer Worldwide Research and Development, Groton, Connecticut, USA.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Oct; Vol. 116 (4), pp. 996-1004. Date of Electronic Publication: 2024 May 26.
Autor:
Singh GJP; BBSG Pharm Associates, LLC. Corona, CA 92883, USA. Electronic address: gjps@bbsgpharm.com.
Publikováno v:
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences [Eur J Pharm Sci] 2024 Oct 01; Vol. 201, pp. 106872. Date of Electronic Publication: 2024 Aug 06.
Autor:
Manners A; OPKO Pharmaceuticals LLC., a subsidiary of OPKO Health, Inc., Miami, USA., Korth-Bradley J; Pfizer, New York, NY, USA., Wajnrajch MP; Pfizer, New York, NY, USA and New York University Grossman School of Medicine, New York, NY, USA.
Publikováno v:
Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2024 Oct; Vol. 13 (10), pp. 1108-1114. Date of Electronic Publication: 2024 Jun 24.
Autor:
Chen X; Department of Pharmacy, Uppsala University, Uppsala, Sweden., Nyberg HB; Department of Pharmacy, Uppsala University, Uppsala, Sweden., Donnelly M; Division of Quantitative Methods and Modeling, Office of Research Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Zhao L; Division of Quantitative Methods and Modeling, Office of Research Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Fang L; Division of Quantitative Methods and Modeling, Office of Research Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Karlsson MO; Department of Pharmacy, Uppsala University, Uppsala, Sweden., Hooker AC; Department of Pharmacy, Uppsala University, Uppsala, Sweden.
Publikováno v:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2024 Oct; Vol. 13 (10), pp. 1734-1747. Date of Electronic Publication: 2024 Aug 23.
Autor:
Noskov S; City Hospital No. 3, Yaroslavl, Russia., Arefeva A; R&D Center, GEROPHARM, Saint-Petersburg, Russia., Radaeva K; R&D Center, GEROPHARM, Saint-Petersburg, Russia., Makarenko I; R&D Center, GEROPHARM, Saint-Petersburg, Russia., Gefen M; R&D Center, GEROPHARM, Saint-Petersburg, Russia., Drai R; R&D Center, GEROPHARM, Saint-Petersburg, Russia.
Publikováno v:
Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2024 Oct; Vol. 13 (10), pp. 1123-1129. Date of Electronic Publication: 2024 Jun 16.
Publikováno v:
International journal of clinical pharmacology and therapeutics [Int J Clin Pharmacol Ther] 2024 Oct; Vol. 62 (10), pp. 479-485.